Company Filing History:
1 out of 13 
1 out of 1,290 
1 out of 13 Years Active: 2012-2019
Title: Shizunobu Igimi: Innovator in Lactic Acid Bacteria Research
Introduction
Shizunobu Igimi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of lactic acid bacteria for therapeutic applications. With a total of two patents to his name, his work focuses on innovative solutions for health-related issues.
Latest Patents
Igimi's latest patents include a lactic-acid-bacteria-containing composition designed for treating HPV infections and associated tumors. This composition features a lactic acid bacterium that presents a human papillomavirus (HPV) E7 protein-derived polypeptide on its surface. The specific formulation includes the polypeptide in an amount ranging from 0.03 µg to 1.0 µg per 1×10 lactic acid bacteria. Additionally, he has developed a therapeutic oral pharmaceutical composition that utilizes this lactic acid bacterium-containing composition to address HPV infectious diseases and tumors. Another notable patent involves an obligately anaerobic mutant lactic acid bacterium, which is engineered to be a safe therapeutic agent and gene transporter for diseases in anaerobic environments, such as solid tumors.
Career Highlights
Throughout his career, Shizunobu Igimi has worked with notable organizations, including Anaeropharma Science, Inc. and The University of Tokyo. His research has focused on creating safe and effective therapeutic agents that can operate in anaerobic conditions, showcasing his commitment to advancing medical science.
Collaborations
Igimi has collaborated with esteemed colleagues, including Minoru Fujimori and Shun'ichiro Taniguchi. These partnerships have contributed to the development of innovative solutions in the field of biotechnology.
Conclusion
Shizunobu Igimi's work in the realm of lactic acid bacteria represents a significant advancement in therapeutic applications for HPV and other anaerobic diseases. His innovative patents and collaborations highlight his dedication to improving health outcomes through scientific research.